Sky Century InvestmentSKYI -2.00%25 ROA % is 21.52% as of Feb. 2026. GuruFocus rates SKYI with a GF Score™ of 25/100. The stock has 5 warning signs investors should review. Among 1,003 Drug Manufacturers companies, Sky Century Investment ranks worse than 93.72% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sky Century Investment's annualizedNet Income for the quarter that ended in Feb. 2026 was $0.02 Mil.
Sky Century Investment's average Total Assets over the quarter that ended in Feb. 2026 was $0.11 Mil. Therefore, Sky Century Investment's annualized ROA % for the quarter that ended in Feb. 2026 was 21.52%.
The historical rank and industry rank for Sky Century Investment's ROA % or its related term are showing as below:
SKYI'
s ROA % Range Over the Past 10 Years
Min: -2600 Med: -236.52 Max: -40
Current: -67.88
During the past 6 years, Sky Century Investment's highest ROA % was -40.00%. The lowest was -2600.00%. And the median was -236.52%.
SKYI's ROA % is ranked worse than 93.72% of 1003
companies
in the Drug Manufacturers industry
Industry Median: 2.69
vs SKYI: -67.88
Sky Century Investment (OTCPK:SKYI) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Feb. 2026) net income data. The Revenue data used here is four times the quarterly (Feb. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sky Century Investment's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sky Century Investment ROA % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sky Century Investment's ROA % distribution charts can be found below:
* The bar in red indicates where Sky Century Investment's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Feb. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Sky Century Investment (SKYI) has a ROA % of 21.52% as of Feb. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sky Century Investment and its competitors. According to the industry distribution chart, Sky Century Investment ranks #940 out of 1003 companies in the Drug Manufacturers industry, placing it in the top 93.7%.
Is Sky Century Investment's ROA % too high?
Sky Century Investment's current ROA % is 21.52%. The Drug Manufacturers industry median ROA % is 2.69. Sky Century Investment's value of 21.52% is 700% above this industry median. Based on the distribution chart, Sky Century Investment ranks #940 out of 1003 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sky Century Investment has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Sky Century Investment's ROA % compare to IMCC and PLSH?
According to the Drug Manufacturers industry distribution chart, Sky Century Investment ranks #940 out of 1003 companies for ROA %. This places Sky Century Investment in the lower half of its industry. The industry median ROA % is 2.69. Sky Century Investment's value of 21.52% is 700% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.69, based on 1,003 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sky Century Investment's current ROA % of 21.52% is 700% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sky Century Investment and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sky Century Investment's current ROA % is 21.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sky Century Investment stock overvalued right now?
Sky Century Investment (SKYI) has a current ROA % of 21.52%. The current ROA % is 21.52% and 700% above the Drug Manufacturers industry median of 2.69. Sky Century Investment's overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Sky Century Investment (SKYI), the current ROA % is 21.52% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sky Century Investment Inc operates four primary business lines, with profits generated from IT Services, including Technical Support and Server Leasing, and from the sale of RSS feeds and Podcasts. The IT Services segment provides ongoing technical support, maintenance, system upgrades, and high-performance server leasing, supporting growing demand for cloud solutions, data management, and network infrastructure. The Company also owns the Cannabis News application, a mobile platform that aggregates cannabis-related news from diverse sources and delivers real-time updates, though it is not commercially viable and has not generated revenue to date. The Company operates in competitive markets across IT services, marketing services, RSS feed services, and the cannabis industry.
25GF Score
Get the complete analysis for SKYI
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKYI has been successfully added to your 
